The Valley Desk

NCT07650916 · Interventional trial

A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed

Overall registry status Recruiting

Phase 3

Conditions HIV

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov